Runben Biotechnology Co., Ltd. (SHA:603193)

China flag China · Delayed Price · Currency is CNY
26.62
+0.65 (2.50%)
May 6, 2026, 3:00 PM CST
Market Cap10.77B -24.2%
Revenue (ttm)1.57B +13.0%
Net Income322.94M +4.6%
EPS0.80 +5.5%
Shares Out404.59M
PE Ratio33.30
Forward PE28.62
Dividend0.46 (1.77%)
Ex-Dividend Daten/a
Volume6,978,747
Average Volume7,033,825
Open26.00
Previous Close25.97
Day's Range25.88 - 26.78
52-Week Range20.28 - 44.00
Beta0.41
RSI60.83
Earnings DateApr 23, 2026

About Runben Biotechnology

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. The company sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 1993 and is based in Guangzhou, China.Runben Biotechnology Co., Ltd. operates as a subsidiary of Guangzhou Zhuofan Investment Holding Co., Ltd [Read more]

Founded 1993
Employees 921
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603193
Full Company Profile

Financial Performance

In 2025, Runben Biotechnology's revenue was 1.54 billion, an increase of 17.19% compared to the previous year's 1.32 billion. Earnings were 314.50 million, an increase of 4.78%.

Financial Statements